caffeine has been researched along with Cardiovascular Diseases in 146 studies
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this experimental whole-heart study, treatment with caffeine and taurine provoked ventricular arrhythmias." | 8.12 | Cardiovascular risk of energy drinks: Caffeine and taurine facilitate ventricular arrhythmias in a sensitive whole-heart model. ( Eckardt, L; Ellermann, C; Frommeyer, G; Hakenes, T; Leitz, P; Rath, B; Wegner, FK; Willy, K; Wolfes, J, 2022) |
| "Caffeine is a most widely consumed physiological stimulant worldwide, which is consumed via natural sources, such as coffee and tea, and now marketed sources such as energy drinks and other dietary supplements." | 6.53 | Caffeine and cardiovascular diseases: critical review of current research. ( Hayes, A; Klimas, J; Kobyliak, N; Kruzliak, P; Kubatka, P; La Rocca, G; Loftus, H; Novak, J; Pohanka, M; Qaradakhi, T; Smith, RM; Soucek, M; Uehara, Y; Zagatina, A; Zulli, A, 2016) |
| "Caffeine has well-known short-term stimulating effects on central nervous system, but the long-term impacts on cognition have been less clear." | 5.36 | Caffeine as a protective factor in dementia and Alzheimer's disease. ( Eskelinen, MH; Kivipelto, M, 2010) |
| " An inverse association between coffee consumption and all-cause mortality was maintained irrespective of age, overweight status, alcohol drinking, smoking status, and caffeine content of coffee." | 5.01 | Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers. ( Giovannucci, E; Je, Y; Kim, Y, 2019) |
| " However, caffeine at high doses can increase anxiety, insomnia, calcium loss and possibly the risk of fractures." | 4.89 | Coffee and tea: perks for health and longevity? ( Bhatti, SK; Lavie, CJ; O'Keefe, JH, 2013) |
| "This paper reviews the literature on the genetics of caffeine from the following: (1) twin studies comparing heritability of consumption and of caffeine-related traits, including withdrawal symptoms, caffeine-induced insomnia, and anxiety, (2) association studies linking genetic polymorphisms of metabolic enzymes and target receptors to variations in caffeine response, and (3) case-control and prospective studies examining relationship between polymorphisms associated with variations in caffeine response to risks of Parkinson's and cardiovascular diseases in habitual caffeine consumers." | 4.86 | Genetics of caffeine consumption and responses to caffeine. ( de Wit, H; Palmer, AA; Yang, A, 2010) |
| "In this experimental whole-heart study, treatment with caffeine and taurine provoked ventricular arrhythmias." | 4.12 | Cardiovascular risk of energy drinks: Caffeine and taurine facilitate ventricular arrhythmias in a sensitive whole-heart model. ( Eckardt, L; Ellermann, C; Frommeyer, G; Hakenes, T; Leitz, P; Rath, B; Wegner, FK; Willy, K; Wolfes, J, 2022) |
| " However, the effects of coffee on arterial hypertension are still objects of active discussion mainly because of the debated effects of caffeine on blood pressure and cardiovascular system." | 4.12 | Coffee and blood pressure: exciting news! ( Borghi, C, 2022) |
| " Sprague-Dawley rats were dosed daily by gavage for 28 days with 10 or 50 mg of synephrine/kg body weight from one of two different extracts; caffeine was added to some doses." | 3.79 | Cardiovascular toxicity of Citrus aurantium in exercised rats. ( Abdel-Rahman, A; Fabricant, D; George, NI; Hansen, DK; Pellicore, LS; White, GE, 2013) |
| " Pharmaceutical costs were evaluated in 73 of 220 subjects taking medications for diabetes, hyperlipidemia, or hypertension before and after treatment using fenfluramine with mazindol or phentermine." | 3.70 | Pharmaceutical cost savings of treating obesity with weight loss medications. ( Bray, GA; Greenway, FL; Rood, JC; Ryan, DH; Smith, SR; Tucker, EW, 1999) |
| "These findings do not support the hypothesis that coffee or caffeine consumption increases the risk of coronary heart disease or stroke." | 3.68 | Coffee, caffeine, and cardiovascular disease in men. ( Colditz, G; Giovannucci, E; Grobbee, DE; Rimm, EB; Stampfer, M; Willett, W, 1990) |
| "The incidence of cardiovascular diseases has significantly increased with the expansion of the industrialization of societies, which is notably linked to lifestyle changes and an unhealthy diet." | 3.01 | Effect of Caffeine Consumption on Cardiovascular Disease: An Updated Review. ( Agabalazadeh, A; Bannazadeh Baghi, H; Entezari-Maleki, T; Khiali, S; Rahbari Banaeian, G; Sahrai, H, 2023) |
| "Some recent epidemiologic studies have reported a nonlinear dose-response in the relationship between coffee consumption and health risks, such that the risks increase disproportionately to the increase in dose." | 2.67 | Dose-dependency of caffeine metabolism with repeated dosing. ( Benowitz, NL; Brown, CR; Denaro, CP; Jacob, P; Wilson, M, 1990) |
| "Caffeine intake has been associated with a range of reversible and transient physiological effects broadly and cardiovascular effects specifically." | 2.55 | Caffeine and cardiovascular health. ( Chowdhury, F; Mariano, GF; Rodricks, JV; Turnbull, D, 2017) |
| "Caffeine is a most widely consumed physiological stimulant worldwide, which is consumed via natural sources, such as coffee and tea, and now marketed sources such as energy drinks and other dietary supplements." | 2.53 | Caffeine and cardiovascular diseases: critical review of current research. ( Hayes, A; Klimas, J; Kobyliak, N; Kruzliak, P; Kubatka, P; La Rocca, G; Loftus, H; Novak, J; Pohanka, M; Qaradakhi, T; Smith, RM; Soucek, M; Uehara, Y; Zagatina, A; Zulli, A, 2016) |
| "The objective of this evidence-based review was to examine whether supplementation with l-arginine, in combination with caffeine and/or creatine, is safe and whether it enhances athletic performance or improves recovery from exhaustion for military personnel." | 2.53 | Safety and performance benefits of arginine supplements for military personnel: a systematic review. ( Barrett, ML; Brooks, JR; Cantilena, L; Chung, M; Costello, RB; Deuster, P; Dwyer, J; Giancaspro, GI; Gorecki, DK; Hardy, ML; Jones, D; Jordan, SA; Low Dog, T; Marles, RJ; Maughan, RJ; Oketch-Rabah, H; Osterberg, RE; Rodda, BE; Sarma, ND; Valerio, LG; Wolfe, RR; Zuniga, JM, 2016) |
| " The bioavailability and the distribution of each compound and its metabolites also contribute to coffee mechanisms of action." | 2.50 | Coffee components and cardiovascular risk: beneficial and detrimental effects. ( Buscemi, S; Galvano, F; Godos, J; Grosso, G; Li Volti, G; Marventano, S; Pluchinotta, FR, 2014) |
| " Recent and significant literature describing adverse events associated with energy drink use are reviewed." | 2.48 | Toxicity of energy drinks. ( Babu, KM; Ganetsky, M; Wolk, BJ, 2012) |
| "Caffeine is a stimulant of central nervous system and therefore is probably the most commonly used psychoactive substance in the world." | 2.48 | [Caffeine--common ingredient in a diet and its influence on human health]. ( Wierzejska, R, 2012) |
| "Caffeine is a widespread known psychoactive substance that is present mainly in coffee, tea, soft and energy drinks." | 2.47 | [Coffee and caffeine - enemies or alliantes of a cardiologist?]. ( Anielska, E; Burdan, F; Dworzański, W; Jaskólska, A; Szumiło, M, 2011) |
| "Caffeine has also been recently linked to weight loss and consequent reduction of the overall risks for developing the metabolic syndrome." | 2.46 | Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. ( Gonzalez de Mejia, E; Heckman, MA; Weil, J, 2010) |
| "Caffeine is a methylxanthine whose primary biological effect is the competitive antagonism of the adenosine receptor." | 2.39 | Caffeine and coffee: effects on health and cardiovascular disease. ( Benowitz, NL; Chou, TM, 1994) |
| " Chronic use of EDs should be especially discouraged to avoid these negative effects." | 1.56 | The metabolic disorders associated with chronic consumption of soft and energy drinks in rats. ( Abouzied, M; Alahmadi, YM; Alamri, A; Alamri, G; Aloufi, A; Bahashwan, S; Elbadawy, H; Elbadawy, HM; Eltahir, HM; Nazmy, M, 2020) |
| "Caffeine intake was marginally inversely associated with coronary artery calcium progression." | 1.46 | Associations of Coffee, Tea, and Caffeine Intake with Coronary Artery Calcification and Cardiovascular Events. ( Averill, M; Blumenthal, RS; Burke, GL; Frazier-Wood, AC; Guallar, E; Lima, JAC; Martin, SS; Michos, ED; Miller, PE; Polak, JF; Post, WS; Sandfort, V; Zhao, D, 2017) |
| "Obesity was defined as BMI > 30." | 1.42 | Associations between night work and BMI, alcohol, smoking, caffeine and exercise--a cross-sectional study. ( Bjorvatn, B; Buchvold, HV; Pallesen, S; Øyane, NM, 2015) |
| "Caffeine has well-known short-term stimulating effects on central nervous system, but the long-term impacts on cognition have been less clear." | 1.36 | Caffeine as a protective factor in dementia and Alzheimer's disease. ( Eskelinen, MH; Kivipelto, M, 2010) |
| "Treatment of cardiac arrhythmia by repeated intravenous injections of propranolol (1 mg/kg) or verapamil (1 mg/kg) was effective and prolonged survival time to 91." | 1.30 | Experimental treatment of the acute cardiovascular toxicity of caffeine. ( Diederich, KW; Strubelt, O, 1999) |
| "The caffeine-modified ECT treatments were well tolerated and were associated with no clinically significant adverse cardiovascular effects." | 1.28 | Caffeine-modified electroconvulsive therapy in depressed patients with medical illness. ( Coffey, CE; Lurie, SN, 1990) |
| " Thus, long-term administration of caffeine to Sprague-Dawley rats is associated with markedly reduced life-span due to cardiovascular disease." | 1.26 | Cardiovascular lesions in Sprague-Dawley rats induced by long-term treatment with caffeine. ( Johansson, S, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (15.07) | 18.7374 |
| 1990's | 19 (13.01) | 18.2507 |
| 2000's | 26 (17.81) | 29.6817 |
| 2010's | 61 (41.78) | 24.3611 |
| 2020's | 18 (12.33) | 2.80 |
| Authors | Studies |
|---|---|
| Morgenstern, JD | 1 |
| Rosella, LC | 1 |
| Costa, AP | 1 |
| Anderson, LN | 1 |
| Ellermann, C | 1 |
| Hakenes, T | 1 |
| Wolfes, J | 1 |
| Wegner, FK | 1 |
| Willy, K | 1 |
| Leitz, P | 1 |
| Rath, B | 1 |
| Eckardt, L | 1 |
| Frommeyer, G | 1 |
| Borghi, C | 2 |
| Bragagni, A | 1 |
| van Dam, RM | 6 |
| Hu, FB | 5 |
| Hou, C | 1 |
| Zeng, Y | 1 |
| Chen, W | 1 |
| Han, X | 1 |
| Yang, H | 1 |
| Ying, Z | 1 |
| Hu, Y | 1 |
| Sun, Y | 1 |
| Qu, Y | 1 |
| Fang, F | 1 |
| Song, H | 1 |
| Inoue-Choi, M | 1 |
| Ramirez, Y | 1 |
| Cornelis, MC | 3 |
| Berrington de González, A | 1 |
| Freedman, ND | 1 |
| Loftfield, E | 2 |
| Bevilacqua, E | 1 |
| Cruzat, V | 1 |
| Singh, I | 1 |
| Rose'Meyer, RB | 1 |
| Panchal, SK | 1 |
| Brown, L | 1 |
| Virgili, J | 1 |
| Motitis, P | 1 |
| Julal, G | 1 |
| Mavrommatis, Y | 1 |
| Pilic, L | 1 |
| Khiali, S | 1 |
| Agabalazadeh, A | 1 |
| Sahrai, H | 1 |
| Bannazadeh Baghi, H | 1 |
| Rahbari Banaeian, G | 1 |
| Entezari-Maleki, T | 1 |
| Coppi, F | 1 |
| Migaldi, M | 1 |
| Stefanelli, C | 1 |
| Farinetti, A | 1 |
| Mattioli, AV | 1 |
| Higashi, Y | 1 |
| Atroszko, PA | 1 |
| Zhou, A | 2 |
| Hyppönen, E | 2 |
| Visser, E | 1 |
| Geleijnse, JM | 1 |
| de Roos, B | 1 |
| Eltahir, HM | 1 |
| Alamri, G | 1 |
| Alamri, A | 1 |
| Aloufi, A | 1 |
| Nazmy, M | 1 |
| Elbadawy, H | 1 |
| Bahashwan, S | 1 |
| Elbadawy, HM | 1 |
| Alahmadi, YM | 1 |
| Abouzied, M | 1 |
| Willett, WC | 1 |
| Weng, Z | 1 |
| Xu, C | 1 |
| Xu, J | 1 |
| Jiang, Z | 1 |
| Liu, Q | 1 |
| Liang, J | 1 |
| Gu, A | 1 |
| Gutiérrez-Hellín, J | 1 |
| Varillas-Delgado, D | 1 |
| Chieng, D | 1 |
| Kistler, PM | 3 |
| Turnbull, D | 1 |
| Rodricks, JV | 1 |
| Mariano, GF | 1 |
| Chowdhury, F | 1 |
| Grosso, G | 2 |
| Godos, J | 2 |
| Galvano, F | 2 |
| Giovannucci, EL | 1 |
| Gökcen, BB | 1 |
| Şanlier, N | 2 |
| Rodríguez-Artalejo, F | 3 |
| López-García, E | 5 |
| Atik, A | 1 |
| Atik, I | 1 |
| James, JE | 3 |
| Caporaso, N | 1 |
| Yu, K | 1 |
| Sinha, R | 1 |
| Freedman, N | 1 |
| Voskoboinik, A | 2 |
| Koh, Y | 1 |
| Lavie, CJ | 2 |
| DiNicolantonio, JJ | 1 |
| O'Keefe, JH | 2 |
| Chagué, F | 1 |
| Georges, M | 1 |
| Gudjoncik, A | 1 |
| Hermerel, T | 1 |
| Garet, G | 1 |
| Israël, J | 1 |
| Hager, JP | 1 |
| Aviat, P | 1 |
| Laurent, Y | 1 |
| Gremeaux, V | 1 |
| Cottin, Y | 1 |
| Zeller, M | 1 |
| Inoue, M | 1 |
| Tsugane, S | 1 |
| Kim, Y | 1 |
| Je, Y | 2 |
| Giovannucci, E | 3 |
| Kitkungvan, D | 1 |
| Bui, L | 1 |
| Johnson, NP | 1 |
| Patel, MB | 1 |
| Roby, AE | 1 |
| Vejpongsa, P | 1 |
| Babar, AK | 1 |
| Madjid, M | 1 |
| Nacimbene, A | 1 |
| Kumar, S | 1 |
| DeGolovine, A | 1 |
| Gould, KL | 1 |
| Byrne, C | 1 |
| Pareek, M | 1 |
| Kjaer, A | 1 |
| Hasbak, P | 1 |
| Bennett, JM | 1 |
| Rodrigues, IM | 2 |
| Klein, LC | 2 |
| Siasos, G | 1 |
| Oikonomou, E | 1 |
| Chrysohoou, C | 1 |
| Tousoulis, D | 1 |
| Panagiotakos, D | 2 |
| Zaromitidou, M | 1 |
| Zisimos, K | 1 |
| Kokkou, E | 1 |
| Marinos, G | 1 |
| Papavassiliou, AG | 1 |
| Pitsavos, C | 1 |
| Stefanadis, C | 3 |
| Hodgson, JM | 1 |
| Croft, KD | 1 |
| Woodman, RJ | 1 |
| Puddey, IB | 1 |
| Fuchs, D | 1 |
| Draijer, R | 1 |
| Lukoshkova, E | 1 |
| Head, GA | 1 |
| Stohs, SJ | 1 |
| Kellner, CH | 1 |
| Bryson, EO | 1 |
| Bhatti, SK | 1 |
| Del Brutto, OH | 1 |
| Mera, RM | 1 |
| Zambrano, M | 1 |
| Kim, J | 2 |
| Shim, J | 1 |
| Lee, CY | 1 |
| Lee, KW | 1 |
| Lee, HJ | 1 |
| Ludwig, IA | 1 |
| Clifford, MN | 1 |
| Lean, ME | 1 |
| Ashihara, H | 1 |
| Crozier, A | 1 |
| Chrysant, SG | 1 |
| Chrysant, GS | 1 |
| Pluchinotta, FR | 1 |
| Marventano, S | 1 |
| Buscemi, S | 1 |
| Li Volti, G | 1 |
| Ramin, C | 1 |
| Devore, EE | 1 |
| Wang, W | 1 |
| Pierre-Paul, J | 1 |
| Wegrzyn, LR | 1 |
| Schernhammer, ES | 1 |
| Whayne, TF | 1 |
| Zhang, C | 1 |
| Qin, YY | 1 |
| Wei, X | 1 |
| Yu, FF | 1 |
| Zhou, YH | 1 |
| He, J | 1 |
| Sanchis-Gomar, F | 1 |
| Pareja-Galeano, H | 1 |
| Cervellin, G | 1 |
| Lippi, G | 2 |
| Earnest, CP | 1 |
| Buchvold, HV | 1 |
| Pallesen, S | 1 |
| Øyane, NM | 1 |
| Bjorvatn, B | 1 |
| Wilson, PW | 1 |
| Bloom, HL | 1 |
| Zulli, A | 1 |
| Smith, RM | 1 |
| Kubatka, P | 1 |
| Novak, J | 1 |
| Uehara, Y | 1 |
| Loftus, H | 1 |
| Qaradakhi, T | 1 |
| Pohanka, M | 1 |
| Kobyliak, N | 1 |
| Zagatina, A | 1 |
| Klimas, J | 1 |
| Hayes, A | 1 |
| La Rocca, G | 1 |
| Soucek, M | 1 |
| Kruzliak, P | 1 |
| De Caterina, R | 1 |
| El-Sohemy, A | 1 |
| Rodenbeck, SD | 1 |
| Zarse, CA | 1 |
| McKenney-Drake, ML | 1 |
| Bruning, RS | 1 |
| Sturek, M | 1 |
| Chen, NX | 1 |
| Moe, SM | 1 |
| Miller, PE | 1 |
| Zhao, D | 1 |
| Frazier-Wood, AC | 1 |
| Michos, ED | 1 |
| Averill, M | 1 |
| Sandfort, V | 1 |
| Burke, GL | 1 |
| Polak, JF | 1 |
| Lima, JAC | 1 |
| Post, WS | 1 |
| Blumenthal, RS | 1 |
| Guallar, E | 1 |
| Martin, SS | 1 |
| Karatzi, K | 2 |
| Aissopou, EK | 1 |
| Katsana, K | 1 |
| Moiragia, M | 1 |
| Tentolouris, N | 1 |
| Sfikakis, PP | 1 |
| Protogerou, AD | 1 |
| Brooks, JR | 1 |
| Oketch-Rabah, H | 1 |
| Low Dog, T | 1 |
| Gorecki, DK | 1 |
| Barrett, ML | 1 |
| Cantilena, L | 1 |
| Chung, M | 1 |
| Costello, RB | 1 |
| Dwyer, J | 1 |
| Hardy, ML | 1 |
| Jordan, SA | 1 |
| Maughan, RJ | 1 |
| Marles, RJ | 1 |
| Osterberg, RE | 1 |
| Rodda, BE | 1 |
| Wolfe, RR | 1 |
| Zuniga, JM | 1 |
| Valerio, LG | 1 |
| Jones, D | 1 |
| Deuster, P | 1 |
| Giancaspro, GI | 1 |
| Sarma, ND | 1 |
| Li, TY | 3 |
| Hallas, J | 1 |
| Bjerrum, L | 1 |
| Støvring, H | 1 |
| Andersen, M | 1 |
| Greenberg, JA | 1 |
| Chow, G | 1 |
| Ziegelstein, RC | 1 |
| Riksen, NP | 1 |
| Rongen, GA | 1 |
| Smits, P | 1 |
| Brown, CM | 1 |
| Dulloo, AG | 1 |
| Montani, JP | 1 |
| Silletta, MG | 1 |
| Marchioli, R | 1 |
| Zhang, W | 2 |
| Zhang, WL | 1 |
| Balk, L | 1 |
| Hoekstra, T | 1 |
| Twisk, J | 1 |
| Stensel, D | 1 |
| Chen, Y | 1 |
| Tu, JH | 1 |
| He, YJ | 1 |
| Wang, G | 1 |
| Tan, ZR | 1 |
| Zhou, G | 1 |
| Fan, L | 1 |
| Zhou, HH | 1 |
| Mineharu, Y | 1 |
| Koizumi, A | 1 |
| Wada, Y | 1 |
| Iso, H | 1 |
| Watanabe, Y | 1 |
| Date, C | 1 |
| Yamamoto, A | 1 |
| Kikuchi, S | 1 |
| Inaba, Y | 1 |
| Toyoshima, H | 1 |
| Kondo, T | 1 |
| Tamakoshi, A | 1 |
| Eskelinen, MH | 1 |
| Kivipelto, M | 1 |
| Harris, RA | 1 |
| Nishiyama, SK | 1 |
| Wray, DW | 1 |
| Richardson, RS | 1 |
| Heckman, MA | 1 |
| Weil, J | 1 |
| Gonzalez de Mejia, E | 1 |
| Yang, A | 1 |
| Palmer, AA | 1 |
| de Wit, H | 1 |
| Bergey, MR | 1 |
| Steele, MS | 1 |
| Bereiter, DA | 1 |
| Viali, S | 1 |
| McGarvey, ST | 1 |
| Beaudoin, MS | 1 |
| Graham, TE | 1 |
| Dworzański, W | 1 |
| Burdan, F | 1 |
| Szumiło, M | 1 |
| Jaskólska, A | 1 |
| Anielska, E | 1 |
| Mesas, AE | 1 |
| Leon-Muñoz, LM | 1 |
| Floegel, A | 1 |
| Pischon, T | 1 |
| Bergmann, MM | 1 |
| Teucher, B | 1 |
| Kaaks, R | 1 |
| Boeing, H | 1 |
| Montagnana, M | 1 |
| Favaloro, EJ | 1 |
| Wolk, BJ | 1 |
| Ganetsky, M | 1 |
| Babu, KM | 1 |
| Wierzejska, R | 1 |
| Hermansen, K | 1 |
| Krogholm, KS | 1 |
| Bech, BH | 1 |
| Dragsted, LO | 1 |
| Hyldstrup, L | 1 |
| Jørgensen, K | 1 |
| Larsen, ML | 1 |
| Tjønneland, AM | 1 |
| Hansen, DK | 1 |
| George, NI | 1 |
| White, GE | 1 |
| Abdel-Rahman, A | 1 |
| Pellicore, LS | 1 |
| Fabricant, D | 1 |
| Kalman, D | 1 |
| Incledon, T | 1 |
| Gaunaurd, I | 1 |
| Schwartz, H | 1 |
| Krieger, D | 1 |
| Nawrot, P | 1 |
| Jordan, S | 1 |
| Eastwood, J | 1 |
| Rotstein, J | 1 |
| Hugenholtz, A | 1 |
| Feeley, M | 1 |
| Cameron, J | 1 |
| Grassi, G | 1 |
| Landry, GL | 1 |
| NAGYVARADI, J | 1 |
| CASASOLA, M | 1 |
| DI LENARDA, B | 1 |
| HOOK, G | 1 |
| Papaioannou, TG | 1 |
| Karatzis, E | 1 |
| Papamichael, C | 1 |
| Lekakis, JP | 1 |
| Vlachopoulos, C | 2 |
| Ioakeimidis, N | 1 |
| Dima, I | 2 |
| Higdon, JV | 1 |
| Frei, B | 1 |
| Rempher, KJ | 1 |
| Alexopoulos, N | 1 |
| Aznaouridis, K | 1 |
| Andreadou, I | 1 |
| Hamer, M | 1 |
| Bonita, JS | 1 |
| Mandarano, M | 1 |
| Shuta, D | 1 |
| Vinson, J | 1 |
| George, SE | 1 |
| Ramalakshmi, K | 1 |
| Mohan Rao, LJ | 1 |
| Johansson, S | 1 |
| Egan, B | 1 |
| Julius, S | 1 |
| Ernster, VL | 2 |
| Bjelke, E | 1 |
| Bernstein, E | 1 |
| Diskant, BM | 1 |
| Krushinskiĭ, LV | 2 |
| Efuni, SN | 2 |
| Demurov, EA | 2 |
| Flëss, DA | 2 |
| Semiokhina, AF | 2 |
| Lamarine, RJ | 1 |
| Chou, TM | 1 |
| Benowitz, NL | 3 |
| Thompson, WG | 1 |
| Barone, JJ | 1 |
| Grice, HC | 2 |
| Houston, DK | 1 |
| Johnson, MA | 1 |
| Daniel, TD | 1 |
| Poon, LW | 1 |
| Strubelt, O | 1 |
| Diederich, KW | 1 |
| Misra, T | 1 |
| Gilchrist, JS | 1 |
| Russell, JC | 1 |
| Pierce, GN | 1 |
| Klein, BE | 1 |
| Klein, R | 1 |
| Lee, KE | 1 |
| Bruskewitz, RC | 1 |
| Greenway, FL | 1 |
| Ryan, DH | 1 |
| Bray, GA | 1 |
| Rood, JC | 1 |
| Tucker, EW | 1 |
| Smith, SR | 1 |
| Poulsen, PL | 1 |
| Møller, N | 1 |
| Schmitz, O | 1 |
| Mogensen, CE | 1 |
| Cuomo, V | 1 |
| Cristallo, E | 1 |
| Marino, A | 1 |
| Stocksmeier, U | 1 |
| Bonk, S | 1 |
| Nickel, C | 1 |
| Schroeter, M | 1 |
| Hemzacek, KI | 1 |
| Dawber, TR | 1 |
| Saxena, VK | 1 |
| De Deyn, PP | 1 |
| Elmer, PJ | 1 |
| Siegel, D | 1 |
| Benowitz, N | 1 |
| Grady, DG | 1 |
| Hauck, WW | 1 |
| Grobbee, DE | 1 |
| Rimm, EB | 1 |
| Colditz, G | 1 |
| Stampfer, M | 1 |
| Willett, W | 1 |
| Lurie, SN | 1 |
| Coffey, CE | 1 |
| Denaro, CP | 1 |
| Brown, CR | 1 |
| Wilson, M | 1 |
| Jacob, P | 1 |
| Barone, J | 1 |
| Martínez, A | 1 |
| Izquierdo, R | 1 |
| Balanzategui, I | 1 |
| Curb, JD | 1 |
| Reed, DM | 1 |
| Kautz, JA | 1 |
| Yano, K | 1 |
| Hickey, RJ | 1 |
| Clelland, RC | 1 |
| Harner, EB | 1 |
| Boyce, DE | 1 |
| Hapke, HJ | 2 |
| Naismith, DJ | 1 |
| Akinyanju, PA | 1 |
| Yudkin, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Energy Drink Ingredients on Cardiovascular Function[NCT04149717] | 35 participants (Anticipated) | Interventional | 2020-01-01 | Recruiting | |||
| Evaluation of the Effect of Espresso on Platelet Aggregability in Patients With Coronary Artery Disease[NCT04827251] | 30 participants (Anticipated) | Interventional | 2019-03-18 | Recruiting | |||
| Effect of Low Intensity Strength Training Combined With Moderate Blood Flow Restriction on Muscle Vasodilatation and Arterial Stiffness in Elders With Low Gait Velocity.[NCT03272737] | 26 participants (Actual) | Interventional | 2018-02-04 | Completed | |||
| Effect of Intermittent Hypoxia on Ischemia-reperfusion Injury in Healthy Individuals[NCT05423470] | 41 participants (Actual) | Interventional | 2019-05-30 | Completed | |||
| Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer[NCT02549534] | 29 participants (Actual) | Observational | 2015-09-30 | Completed | |||
| The Effect of Caffeine on the Narcoleptic Patients Randomized Controlled Clinical Trial[NCT02832336] | Phase 1/Phase 2 | 16 participants (Actual) | Interventional | 2016-10-01 | Completed | ||
| Neuroplastic Alterations of the Motor Cortex by Caffeine: Differences Between Caffeine and Non-caffeine Users and Influence of Vigilance During Stimulation[NCT04011670] | 30 participants (Actual) | Interventional | 2019-07-15 | Completed | |||
| Effect of Coffee and Tea Consumption on Adolescent Weight Control - a Randomized Clinical Trial[NCT05181176] | 63 participants (Anticipated) | Interventional | 2021-01-01 | Recruiting | |||
| Cortical Excitability Changes on the Sensorimotor Cortex Induced by Caffeine Consumption: A TMS Study[NCT03720665] | 30 participants (Actual) | Interventional | 2018-10-01 | Completed | |||
| Does Caffeine Enhance Bowel Recovery After Colorectal Surgery?[NCT03097900] | Phase 2 | 70 participants (Actual) | Interventional | 2017-11-02 | Completed | ||
| [NCT00005182] | 50,000 participants (Actual) | Observational | 1985-12-31 | Completed | |||
| [NCT00005123] | 0 participants | Observational | 1965-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
58 reviews available for caffeine and Cardiovascular Diseases
| Article | Year |
|---|---|
The Potential of Spent Coffee Grounds in Functional Food Development.
Topics: Animals; Caffeine; Cardiovascular Diseases; Coffee; Functional Food; Humans; Rats | 2023 |
The impact of genetic variability on the relationship between caffeine and cardiometabolic outcomes: A systematic review.
Topics: Adult; Caffeine; Cardiovascular Diseases; Cross-Sectional Studies; Cytochrome P-450 CYP1A2; Diabetes | 2023 |
Effect of Caffeine Consumption on Cardiovascular Disease: An Updated Review.
Topics: Blood Pressure; Caffeine; Cardiovascular Diseases; Coffee; Humans | 2023 |
Coffee and Endothelial Function: A Coffee Paradox?
Topics: Caffeine; Cardiovascular Diseases; Coffee; Endothelium, Vascular; Humans | 2019 |
Inter-Individual Variation in Cancer and Cardiometabolic Health Outcomes in Response to Coffee Consumption: A Critical Review.
Topics: Alcohol Drinking; Caffeine; Cardiovascular Diseases; Coffee; Female; Humans; Male; Neoplasms; Polymo | 2020 |
Coffee, Caffeine, and Health.
Topics: Caffeine; Cardiovascular Diseases; Cholesterol; Coffee; Diabetes Mellitus, Type 2; Diterpenes; Human | 2020 |
Energy Drinks and Sports Performance, Cardiovascular Risk, and Genetic Associations; Future Prospects.
Topics: Adolescent; Athletes; Athletic Performance; Caffeine; Cardiovascular Diseases; Cognition; Energy Dri | 2021 |
Coffee and tea on cardiovascular disease (CVD) prevention.
Topics: Adult; Caffeine; Cardiovascular Diseases; Coffee; Humans; Lipids; Risk Factors; Tea | 2022 |
Caffeine and cardiovascular health.
Topics: Caffeine; Cardiovascular Diseases; Cardiovascular System; Central Nervous System Stimulants; Coffee; | 2017 |
Coffee, Caffeine, and Health Outcomes: An Umbrella Review.
Topics: Caffeine; Cardiovascular Diseases; Coffee; Diabetes Mellitus, Type 2; Female; Humans; Male; Neoplasm | 2017 |
Coffee consumption and disease correlations.
Topics: Caffeine; Cardiovascular Diseases; Chlorogenic Acid; Coffee; Diabetes Mellitus, Type 2; Diterpenes; | 2019 |
Coffee Consumption and Cardiovascular Disease: A Condensed Review of Epidemiological Evidence and Mechanisms.
Topics: Aged; Blood Pressure; Caffeine; Cardiovascular Diseases; Coffee; Female; Humans; Hypertension; Male; | 2018 |
Consumption of green coffee and the risk of chronic diseases.
Topics: Caffeine; Cardiovascular Diseases; Chlorogenic Acid; Chronic Disease; Coffee; Humans; Phenols | 2019 |
Are coffee's alleged health protective effects real or artifact? The enduring disjunction between relevant experimental and observational evidence.
Topics: Artifacts; Caffeine; Cardiovascular Diseases; Coffee; Diabetes Mellitus, Type 2; Humans; Hypertensio | 2018 |
Cardiovascular effects of caffeinated beverages.
Topics: Administration, Oral; Animals; Caffeine; Cardiovascular Diseases; Cardiovascular System; Central Ner | 2019 |
Coffee Drinking and Reduced Risk of Liver Cancer: Update on Epidemiological Findings and Potential Mechanisms.
Topics: Antioxidants; Caffeine; Cardiovascular Diseases; Chlorogenic Acid; Coffee; Diabetes Mellitus; Drinki | 2019 |
Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers.
Topics: Alcohol Drinking; Caffeine; Cardiovascular Diseases; Causality; Cause of Death; Coffee; Europe; Fema | 2019 |
Coffee and tea: perks for health and longevity?
Topics: Antioxidants; Anxiety; Blood Glucose; Blood Pressure; Caffeine; Calcium; Cardiovascular Diseases; Co | 2013 |
Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies.
Topics: Adult; Caffeine; Cardiovascular Diseases; Coffee; Cohort Studies; Diet; Europe; Evidence-Based Medic | 2014 |
Cocoa phytochemicals: recent advances in molecular mechanisms on health.
Topics: Animals; Biological Availability; Cacao; Caffeine; Cardiovascular Diseases; Diabetes Mellitus; Flavo | 2014 |
Coffee: biochemistry and potential impact on health.
Topics: Alkaloids; Animals; Antioxidants; Caffeine; Cardiovascular Diseases; Chlorogenic Acid; Coffee; Diabe | 2014 |
Cardiovascular complications from consumption of high energy drinks: recent evidence.
Topics: Alcohol Drinking; Blood Pressure; Caffeine; Cardiovascular Diseases; Central Nervous System Stimulan | 2015 |
Coffee components and cardiovascular risk: beneficial and detrimental effects.
Topics: Alkaloids; Caffeine; Cardiovascular Diseases; Cardiovascular System; Chlorogenic Acid; Coffee; Diabe | 2014 |
Coffee: A Selected Overview of Beneficial or Harmful Effects on the Cardiovascular System?
Topics: Animals; Caffeine; Cardiovascular Diseases; Cardiovascular System; Coffee; Humans; Polyphenols; Risk | 2015 |
Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies.
Topics: Caffeine; Cardiovascular Diseases; Cerebral Hemorrhage; Coronary Disease; Female; Humans; Mortality; | 2015 |
Energy drink overconsumption in adolescents: implications for arrhythmias and other cardiovascular events.
Topics: Adolescent; Adolescent Behavior; Arrhythmias, Cardiac; Caffeine; Cardiovascular Diseases; Energy Dri | 2015 |
Caffeine and cardiovascular diseases: critical review of current research.
Topics: Animals; Blood Vessels; Caffeine; Cardiovascular Diseases; Clinical Studies as Topic; Coffee; Diseas | 2016 |
Moving towards Specific Nutrigenetic Recommendation Algorithms: Caffeine, Genetic Variation and Cardiovascular Risk.
Topics: Algorithms; Blood Pressure; Caffeine; Cardiovascular Diseases; Cardiovascular System; Genetic Variat | 2016 |
Safety and performance benefits of arginine supplements for military personnel: a systematic review.
Topics: Arginine; Athletic Performance; Caffeine; Cardiovascular Diseases; Creatine; Dietary Supplements; Ga | 2016 |
Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease.
Topics: Blood Pressure; Caffeine; Cardiovascular Diseases; Coffee; Epidemiologic Methods; Hemodynamics; Huma | 2009 |
Sugary drinks in the pathogenesis of obesity and cardiovascular diseases.
Topics: Adiposity; Animals; Beverages; Caffeine; Cardiovascular Diseases; Dietary Sucrose; Dogs; Fructose; H | 2008 |
Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Caffeine; Cardiovascular Diseases; Causality; Central Ne | 2008 |
[Coffee and cardiovascular disease risk: yin and yang].
Topics: Caffeine; Cardiovascular Diseases; Cardiovascular System; Coffee; Confounding Factors, Epidemiologic | 2008 |
Primary prevention of CVD: physical activity.
Topics: Age Factors; Caffeine; Cardiovascular Diseases; Gastrointestinal Diseases; Humans; Longitudinal Stud | 2007 |
Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters.
Topics: Animals; Beverages; Caffeine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Food Analysis; Hum | 2010 |
Genetics of caffeine consumption and responses to caffeine.
Topics: Animals; Caffeine; Cardiovascular Diseases; Cytochrome P-450 CYP1A2; Drinking Behavior; Humans; Park | 2010 |
Methylxanthines and human health: epidemiological and experimental evidence.
Topics: Adipose Tissue; Adrenal Medulla; Animals; Caffeine; Cardiovascular Diseases; Coffee; Gastrointestina | 2011 |
[Coffee and caffeine - enemies or alliantes of a cardiologist?].
Topics: Blood Pressure; Caffeine; Cardiovascular Diseases; Cholesterol; Coffee; Fetal Growth Retardation; Ho | 2011 |
The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Caffeine; Cardiovascular Diseases; Coffee; Feeding B | 2011 |
Toxicity of energy drinks.
Topics: Adolescent; Caffeine; Cardiovascular Diseases; Child; Drug Interactions; Energy Drinks; Ethanol; Hum | 2012 |
[Caffeine--common ingredient in a diet and its influence on human health].
Topics: Adolescent; Adult; Brain; Caffeine; Cardiovascular Diseases; Central Nervous System Stimulants; Chil | 2012 |
Effects of caffeine on human health.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Bone and Bones; Caffeine; Calcium; Cardiovascula | 2003 |
Ephedrine use is risky business.
Topics: Caffeine; Cardiovascular Diseases; Central Nervous System Diseases; Central Nervous System Stimulant | 2003 |
Acute effects of caffeine on arterial stiffness, wave reflections, and central aortic pressures.
Topics: Aorta; Arteries; Blood Flow Velocity; Blood Pressure; Caffeine; Cardiovascular Diseases; Central Ner | 2005 |
Coffee and health: a review of recent human research.
Topics: Adult; Caffeine; Carcinoma, Hepatocellular; Cardiovascular Diseases; Child; Chlorogenic Acid; Coffee | 2006 |
Coffee and health: a review of recent human research.
Topics: Adult; Caffeine; Carcinoma, Hepatocellular; Cardiovascular Diseases; Child; Chlorogenic Acid; Coffee | 2006 |
Coffee and health: a review of recent human research.
Topics: Adult; Caffeine; Carcinoma, Hepatocellular; Cardiovascular Diseases; Child; Chlorogenic Acid; Coffee | 2006 |
Coffee and health: a review of recent human research.
Topics: Adult; Caffeine; Carcinoma, Hepatocellular; Cardiovascular Diseases; Child; Chlorogenic Acid; Coffee | 2006 |
Coffee and health: a review of recent human research.
Topics: Adult; Caffeine; Carcinoma, Hepatocellular; Cardiovascular Diseases; Child; Chlorogenic Acid; Coffee | 2006 |
Coffee and health: a review of recent human research.
Topics: Adult; Caffeine; Carcinoma, Hepatocellular; Cardiovascular Diseases; Child; Chlorogenic Acid; Coffee | 2006 |
Coffee and health: a review of recent human research.
Topics: Adult; Caffeine; Carcinoma, Hepatocellular; Cardiovascular Diseases; Child; Chlorogenic Acid; Coffee | 2006 |
Coffee and health: a review of recent human research.
Topics: Adult; Caffeine; Carcinoma, Hepatocellular; Cardiovascular Diseases; Child; Chlorogenic Acid; Coffee | 2006 |
Coffee and health: a review of recent human research.
Topics: Adult; Caffeine; Carcinoma, Hepatocellular; Cardiovascular Diseases; Child; Chlorogenic Acid; Coffee | 2006 |
Cardiovascular sequelae of tobacco smoking.
Topics: Aortic Aneurysm, Abdominal; Arrhythmias, Cardiac; Atherosclerosis; Caffeine; Cardiovascular Diseases | 2006 |
Boiled or filtered coffee? Effects of coffee and caffeine on cholesterol, fibrinogen and C-reactive protein.
Topics: Biomarkers; C-Reactive Protein; Caffeine; Cardiovascular Diseases; Cholesterol; Coffee; Fibrinogen; | 2006 |
Coffee and cardiovascular disease: in vitro, cellular, animal, and human studies.
Topics: Animals; Antioxidants; Blood Pressure; Caffeine; Cardiovascular Diseases; Clinical Trials as Topic; | 2007 |
Epidemiologic studies of caffeine and human health.
Topics: Adult; Age Factors; Aged; Blood Pressure; Caffeine; Cardiovascular Diseases; Epidemiologic Methods; | 1984 |
Selected health and behavioral effects related to the use of caffeine.
Topics: Behavior; Caffeine; Carbonated Beverages; Cardiovascular Diseases; Coffee; Humans; Neoplasms; Nonpre | 1994 |
Caffeine, health and commercial interests.
Topics: Caffeine; Cardiovascular Diseases; Female; Fetal Growth Retardation; Health Education; Humans; Infan | 1994 |
Caffeine and coffee: effects on health and cardiovascular disease.
Topics: Caffeine; Cardiovascular Diseases; Coffee; Humans | 1994 |
Coffee: brew or bane?
Topics: Caffeine; Cardiovascular Diseases; Coffee; Hip Fractures; Humans; Lipids; Neoplasms; Risk Factors; T | 1994 |
Is habitual caffeine use a preventable cardiovascular risk factor?
Topics: Beverages; Blood Pressure; Caffeine; Cardiovascular Diseases; Central Nervous System Stimulants; Hem | 1997 |
Ergotamine: its use in the treatment of migraine and its complications.
Topics: Autonomic Nervous System Diseases; Caffeine; Cardiovascular Diseases; Contraindications; Drug Admini | 1992 |
Dietary methods in cardiovascular disease critique.
Topics: Alcohol Drinking; Caffeine; Calcium, Dietary; Cardiovascular Diseases; Cholesterol, Dietary; Diet; D | 1992 |
Regular or decaf? Coffee consumption and serum lipoproteins.
Topics: Caffeine; Cardiovascular Diseases; Coffee; Humans; Lipoproteins; Male; Middle Aged | 1992 |
Clinical pharmacology of caffeine.
Topics: Abnormalities, Drug-Induced; Caffeine; Cardiovascular Diseases; Humans; Mental Disorders; Risk Facto | 1990 |
7 trials available for caffeine and Cardiovascular Diseases
| Article | Year |
|---|---|
Quantitative myocardial perfusion positron emission tomography and caffeine revisited with new insights on major adverse cardiovascular events and coronary flow capacity.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Aged; Caffeine; Cardiovascular Diseases; Coronary Circula | 2019 |
Black tea lowers the rate of blood pressure variation: a randomized controlled trial.
Topics: Adult; Aged; Australia; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Weight; Caffeine | 2013 |
Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study.
Topics: Adolescent; Adult; Aged; Anti-Obesity Agents; Caffeine; Cardiovascular Diseases; Case-Control Studie | 2008 |
An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.
Topics: Adult; Anti-Obesity Agents; Blood Pressure; Body Mass Index; Caffeine; Cardiovascular Diseases; Doub | 2002 |
Acute effect of black and green tea on aortic stiffness and wave reflections.
Topics: Adult; Aorta; Blood Flow Velocity; Caffeine; Cardiovascular Diseases; Central Nervous System Stimula | 2006 |
Regular or decaf? Coffee consumption and serum lipoproteins.
Topics: Caffeine; Cardiovascular Diseases; Coffee; Humans; Lipoproteins; Male; Middle Aged | 1992 |
Dose-dependency of caffeine metabolism with repeated dosing.
Topics: Adult; Caffeine; Cardiovascular Diseases; Coffee; Dose-Response Relationship, Drug; Female; Humans; | 1990 |
82 other studies available for caffeine and Cardiovascular Diseases
| Article | Year |
|---|---|
Development of machine learning prediction models to explore nutrients predictive of cardiovascular disease using Canadian linked population-based data.
Topics: Caffeine; Canada; Cardiovascular Diseases; Humans; Machine Learning; Nutrients; Risk Assessment | 2022 |
Cardiovascular risk of energy drinks: Caffeine and taurine facilitate ventricular arrhythmias in a sensitive whole-heart model.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Caffeine; Cardiovascular Diseases; Energy Drinks; | 2022 |
[New evidence on coffee consumption, hypertension and cardiovascular diseases].
Topics: Caffeine; Cardiovascular Diseases; Chlorogenic Acid; Coffee; Humans; Hypertension | 2022 |
Caffeine consumption and cardiovascular health.
Topics: Caffeine; Cardiovascular Diseases; Cardiovascular System; Heart; Humans | 2022 |
Medical conditions associated with coffee consumption: Disease-trajectory and comorbidity network analyses of a prospective cohort study in UK Biobank.
Topics: Biological Specimen Banks; Caffeine; Cardiovascular Diseases; Coffee; Cohort Studies; Comorbidity; E | 2022 |
Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank : A Prospective Cohort Study.
Topics: Biological Specimen Banks; Caffeine; Cardiovascular Diseases; Cause of Death; Coffee; Female; Follow | 2022 |
Coffee and blood pressure: exciting news!
Topics: Blood Pressure; Caffeine; Cardiovascular Diseases; Coffee; Humans; Hypertension; Risk Factors | 2022 |
Changes in coffee and caffeine intake during the pandemic in women smokers and non-smokers: a future challenge for cardiovascular prevention.
Topics: Adult; Caffeine; Cardiovascular Diseases; Coffee; Female; Humans; Non-Smokers; Pandemics; Prospectiv | 2023 |
Is a high workload an unaccounted confounding factor in the relation between heavy coffee consumption and cardiovascular disease risk?
Topics: Caffeine; Cardiovascular Diseases; Coffee; Humans; Prospective Studies; Risk Factors; Workload | 2019 |
Reply to PA Atroszko.
Topics: Caffeine; Cardiovascular Diseases; Coffee; Humans; Prospective Studies | 2019 |
The metabolic disorders associated with chronic consumption of soft and energy drinks in rats.
Topics: Animals; Blood Glucose; Caffeine; Carbonated Beverages; Cardiovascular Diseases; Energy Drinks; Kidn | 2020 |
Recent consumption of a caffeine-containing beverage and serum biomarkers of cardiometabolic function in the UK Biobank.
Topics: Adult; Beverages; Biological Specimen Banks; Biomarkers; Caffeine; Cardiovascular Diseases; Coffee; | 2021 |
Association of urinary caffeine and caffeine metabolites with cardiovascular disease risk in adults.
Topics: Adult; Caffeine; Cardiovascular Diseases; Cross-Sectional Studies; Female; Humans; Male; Nutrition S | 2021 |
Association of Coffee Drinking With Mortality by Genetic Variation in Caffeine Metabolism: Findings From the UK Biobank.
Topics: Adult; Aged; Biological Specimen Banks; Caffeine; Cardiovascular Diseases; Cause of Death; Coffee; D | 2018 |
Editorial commentary: Coffee, tea, and cardiovascular morbidity and mortality.
Topics: Beverages; Caffeine; Cardiovascular Diseases; Coffee; Humans; Tea | 2019 |
Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: a prospective analysis of up to 347,077 individuals and 8368 cases.
Topics: Adult; Aged; Caffeine; Cardiovascular Diseases; Coffee; Cytochrome P-450 CYP1A2; Female; Genotype; H | 2019 |
Cardiovascular prevention and at-risk behaviours in a large population of amateur rugby players.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Athletes; Caffeine; Cardiovascular Diseases; Child; Elect | 2019 |
Caffeine and myocardial perfusion: a clinical perspective.
Topics: Caffeine; Cardiovascular Diseases; Humans; Myocardial Perfusion Imaging; Positron-Emission Tomograph | 2019 |
Author's reply: Caffeinated beverages and cardiovascular disease.
Topics: Beverages; Caffeine; Cardiovascular Diseases; Cardiovascular System; Humans | 2019 |
Effects of caffeine and stress on biomarkers of cardiovascular disease in healthy men and women with a family history of hypertension.
Topics: Adolescent; Adult; Blood Pressure; C-Reactive Protein; Caffeine; Cardiovascular Diseases; Female; Fi | 2013 |
Consumption of a boiled Greek type of coffee is associated with improved endothelial function: the Ikaria study.
Topics: Aged; Aged, 80 and over; Brachial Artery; Caffeine; Cardiovascular Diseases; Central Nervous System | 2013 |
Questionable conclusions in the article "Cardiovascular toxicity of Citrus aurantium in exercised rats".
Topics: Animals; Blood Pressure; Caffeine; Cardiovascular Diseases; Citrus; Dose-Response Relationship, Drug | 2013 |
Electroconvulsive therapy anesthesia technique: minimalist versus maximally managed.
Topics: Anesthesia; Anesthetics; Caffeine; Cardiovascular Diseases; Central Nervous System Stimulants; Elect | 2013 |
Cardiovascular health and caffeine consumption. A population-based study in rural Ecuador.
Topics: Aged; Caffeine; Cardiovascular Diseases; Central Nervous System Stimulants; Coffee; Ecuador; Female; | 2014 |
Night shift work at specific age ranges and chronic disease risk factors.
Topics: Adult; Age Factors; Body Mass Index; Caffeine; Cardiovascular Diseases; Chronic Disease; Energy Inta | 2015 |
Associations between night work and BMI, alcohol, smoking, caffeine and exercise--a cross-sectional study.
Topics: Adult; Alcohol Drinking; Body Mass Index; Caffeine; Cardiovascular Diseases; Cross-Sectional Studies | 2015 |
Caffeine Consumption and Cardiovascular Risks: Little Cause for Concern.
Topics: Caffeine; Cardiovascular Diseases; Cardiovascular System; Coffee; Humans; Risk Factors | 2016 |
Intracellular calcium increases in vascular smooth muscle cells with progression of chronic kidney disease in a rat model.
Topics: Animals; Aorta; Caffeine; Calcium; Calcium Gluconate; Cardiovascular Diseases; Cells, Cultured; Dise | 2017 |
Associations of Coffee, Tea, and Caffeine Intake with Coronary Artery Calcification and Cardiovascular Events.
Topics: Aged; Caffeine; Cardiovascular Diseases; Coffee; Coronary Artery Disease; Female; Humans; Male; Midd | 2017 |
Retinal microcirculation in association with caffeinated and alcoholic drinks in subjects at increased cardiovascular risk.
Topics: Adult; Aged; Alcohol Drinking; Arterioles; Caffeine; Cardiovascular Diseases; Coffee; Female; Humans | 2016 |
The relationship of coffee consumption with mortality.
Topics: Caffeine; Cardiovascular Diseases; Cause of Death; Coffee; Drinking Behavior; Female; Follow-Up Stud | 2008 |
Caffeinated coffee consumption, cardiovascular disease, and heart valve disease in the elderly (from the Framingham Study).
Topics: Age Factors; Aged; Aged, 80 and over; Blood Pressure; Caffeine; Cardiovascular Diseases; Coffee; Fem | 2008 |
Coffee consumption and risk of cardiovascular diseases and all-cause mortality among men with type 2 diabetes.
Topics: Adult; Aged; Caffeine; Cardiovascular Diseases; Coffee; Cohort Studies; Diabetes Mellitus, Type 2; F | 2009 |
Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes.
Topics: Adult; Blood Pressure; Caffeine; Cardiovascular Diseases; Coffee; Cohort Studies; Diabetes Mellitus, | 2009 |
Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study.
Topics: Caffeine; Cardiovascular Diseases; Coffee; Diabetes Mellitus, Type 2; Female; Humans; Linear Models; | 2009 |
Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers.
Topics: Adolescent; Adult; Caffeine; Cardiovascular Diseases; Cytochrome P-450 CYP1A2; Enzyme Activation; Hu | 2009 |
Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women.
Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Beverages; Caffeine; Cardiovascular Diseases; Coffe | 2011 |
Caffeine as a protective factor in dementia and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Caffeine; Cardiovascular Diseases; Central Nervous System Stimulants; Coffe | 2010 |
Ultrasound assessment of flow-mediated dilation.
Topics: Arterial Occlusive Diseases; Blood Flow Velocity; Caffeine; Cardiovascular Diseases; Endothelium, Va | 2010 |
Ultrasound assessment of flow-mediated dilation.
Topics: Arterial Occlusive Diseases; Blood Flow Velocity; Caffeine; Cardiovascular Diseases; Endothelium, Va | 2010 |
Ultrasound assessment of flow-mediated dilation.
Topics: Arterial Occlusive Diseases; Blood Flow Velocity; Caffeine; Cardiovascular Diseases; Endothelium, Va | 2010 |
Ultrasound assessment of flow-mediated dilation.
Topics: Arterial Occlusive Diseases; Blood Flow Velocity; Caffeine; Cardiovascular Diseases; Endothelium, Va | 2010 |
Ultrasound assessment of flow-mediated dilation.
Topics: Arterial Occlusive Diseases; Blood Flow Velocity; Caffeine; Cardiovascular Diseases; Endothelium, Va | 2010 |
Ultrasound assessment of flow-mediated dilation.
Topics: Arterial Occlusive Diseases; Blood Flow Velocity; Caffeine; Cardiovascular Diseases; Endothelium, Va | 2010 |
Ultrasound assessment of flow-mediated dilation.
Topics: Arterial Occlusive Diseases; Blood Flow Velocity; Caffeine; Cardiovascular Diseases; Endothelium, Va | 2010 |
Ultrasound assessment of flow-mediated dilation.
Topics: Arterial Occlusive Diseases; Blood Flow Velocity; Caffeine; Cardiovascular Diseases; Endothelium, Va | 2010 |
Ultrasound assessment of flow-mediated dilation.
Topics: Arterial Occlusive Diseases; Blood Flow Velocity; Caffeine; Cardiovascular Diseases; Endothelium, Va | 2010 |
Ecological and sociodemographic effects on urinary catecholamine excretion in adult Samoans.
Topics: Adult; Aged; Caffeine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Demography; Ec | 2011 |
Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study.
Topics: Adult; Aged; Caffeine; Cardiovascular Diseases; Coffee; Cohort Studies; Diabetes Mellitus, Type 2; F | 2012 |
Coffee intake and cardiovascular disease: virtue does not take center stage.
Topics: Adult; Animals; Beverages; Caffeine; Cardiovascular Diseases; Chlorogenic Acid; Cholesterol; Coffee; | 2012 |
Why coffee perks people up. A large study suggests the caffeinated version may boost mood.
Topics: Affect; Caffeine; Cardiovascular Diseases; Central Nervous System Stimulants; Coffee; Depression; Fe | 2012 |
I have heard conflicting advice regarding coffee and caffeine through the years. I had heard caffeine can contribute to high blood pressure, but I just recently read where coffee drinkers who have atrial fibrillation (as I do) have fewer serious rhythm d
Topics: Blood Pressure; Caffeine; Cardiovascular Diseases; Cardiovascular System; Coffee; Feeding Behavior; | 2010 |
Heavy coffee drinkers live longer.
Topics: Caffeine; Cardiovascular Diseases; Central Nervous System Stimulants; Coffee; Feeding Behavior; Heal | 2012 |
[Coffee can protect against disease].
Topics: Alzheimer Disease; Anxiety; Caffeine; Cardiovascular Diseases; Coffee; Cognition; Diabetes Mellitus, | 2012 |
Cardiovascular toxicity of Citrus aurantium in exercised rats.
Topics: Analysis of Variance; Animals; Blood Pressure; Body Temperature; Body Weight; Caffeine; Cardiovascul | 2013 |
Effects of caffeine on arterial function and haemodynamics: implications for cardiovascular risk.
Topics: Arteries; Blood Pressure; Caffeine; Cardiovascular Diseases; Hemodynamics; Humans; Risk Factors | 2003 |
[Studies on the effect of intravenous caffeine in various diseases].
Topics: Blood Pressure; Blood Pressure Determination; Caffeine; Cardiovascular Diseases; Heart Rate; Humans; | 1954 |
[Experiences with a new geriatric drug with circulatory effect].
Topics: Adenine Nucleotides; Aged; Aged, 80 and over; Caffeine; Cardiovascular Diseases; Geriatrics; Niacin; | 1962 |
[Experiences with Trazu in the treatment of hypotensive circulatory disorders].
Topics: Antioxidants; Caffeine; Cardiovascular Diseases; Enzyme Inhibitors; Ephedrine; Glutarates; Glycyrrhi | 1962 |
Chronic coffee consumption has a detrimental effect on aortic stiffness and wave reflections.
Topics: Adult; Aorta; Aortic Diseases; Blood Flow Velocity; Blood Pressure; Caffeine; Cardiovascular Disease | 2005 |
Coffee and health: Explaining conflicting results in hypertension.
Topics: Blood Pressure; Caffeine; Cardiovascular Diseases; Coffee; Female; Humans; Hypertension; Life Style; | 2006 |
A perception on health benefits of coffee.
Topics: Caffeine; Calcium; Cardiovascular Diseases; Central Nervous System Diseases; Coffee; Health Status; | 2008 |
Cardiovascular lesions in Sprague-Dawley rats induced by long-term treatment with caffeine.
Topics: Acetaminophen; Animals; Antipyrine; Caffeine; Cardiovascular Diseases; Heart; Male; Myocardial Infar | 1981 |
Borderline hypertension.
Topics: Alcohol Drinking; Blood Pressure; Body Weight; Caffeine; Cardiovascular Diseases; Catecholamines; Di | 1983 |
[Coffee and risk of cardiovascular diseases].
Topics: Caffeine; Cardiovascular Diseases; Coffee; Female; Humans; Male | 1983 |
Phenylpropanolamine: a potentially hazardous drug.
Topics: Adolescent; Adult; Caffeine; Cardiovascular Diseases; Central Nervous System Diseases; Cerebral Hemo | 1982 |
[Protective action of hyperbaric oxygenation in acute circulatory disorders in rats of different ages].
Topics: Acoustic Stimulation; Acute Disease; Aging; Animals; Caffeine; Cardiovascular Diseases; Female; Hype | 1980 |
[Effect of hyperbaric oxygenation on animal deaths from acute circulatory disorders caused by intense cerebral excitation].
Topics: Acoustic Stimulation; Age Factors; Animals; Caffeine; Cardiovascular Diseases; Hyperbaric Oxygenatio | 1981 |
Seventh International Caffeine Workshop, Santorini, Greece 13-17 June 1993.
Topics: Adolescent; Adult; Bone Density; Caffeine; Calcium; Carbonated Beverages; Cardiovascular Diseases; C | 1994 |
Health and dietary characteristics of supplement users in an elderly population.
Topics: Aged; Aged, 80 and over; Aging; Alcohol Drinking; Ascorbic Acid; Caffeine; Calcium, Dietary; Cardiov | 1997 |
Experimental treatment of the acute cardiovascular toxicity of caffeine.
Topics: Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Arrhythmias, Cardiac; Aspi | 1999 |
Cardiac myofibrillar and sarcoplasmic reticulum function are not depressed in insulin-resistant JCR:LA-cp rats.
Topics: Animals; Caffeine; Calcium; Calcium-Transporting ATPases; Cardiovascular Diseases; Diabetes Mellitus | 1999 |
Correlates of urinary symptom scores in men.
Topics: Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Caffeine; Cardiovascular Diseases; Diabetes | 1999 |
Pharmaceutical cost savings of treating obesity with weight loss medications.
Topics: Adolescent; Adult; Appetite Depressants; Caffeine; Cardiovascular Diseases; Diabetes Mellitus; Drug | 1999 |
[Coffee and diabetes--something to be really concerned about?].
Topics: Caffeine; Cardiovascular Diseases; Coffee; Diabetes Mellitus, Type 2; Feeding Behavior; Humans; Insu | 2002 |
[Interference of psychological stress and of bromazepam with the toxic and electrocardiographic effects of caffeine in guinea pigs].
Topics: Animals; Anti-Anxiety Agents; Bromazepam; Caffeine; Cardiovascular Diseases; Cardiovascular System; | 1975 |
[Studies on the tolerance of coffee in cardiovascular patients].
Topics: Caffeine; Cardiovascular Diseases; Coffee; Double-Blind Method; Humans; Surveys and Questionnaires | 1979 |
Dietary protocol for the patient who has suffered a myocardial infarction.
Topics: Caffeine; Cardiovascular Diseases; Cholesterol, Dietary; Feeding Behavior; Humans; Menu Planning; My | 1978 |
Coffee and cardiovascular disease.
Topics: Acute Disease; Beverages; Caffeine; Cardiovascular Diseases; Coffee; Heart Rate; Humans; Male; Myoca | 1977 |
Coffee and cardiovascular disease.
Topics: Adult; Aged; Caffeine; Cardiovascular Diseases; Feeding Behavior; Female; Humans; Male; Middle Aged; | 1976 |
Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players.
Topics: Adult; Alcohol Drinking; Arizona; Baseball; Black or African American; Caffeine; Cardiovascular Dise | 1992 |
Coffee, caffeine, and cardiovascular disease in men.
Topics: Adult; Aged; Caffeine; Cardiovascular Diseases; Cerebrovascular Disorders; Coffee; Coronary Disease; | 1990 |
Caffeine-modified electroconvulsive therapy in depressed patients with medical illness.
Topics: Aged; Aged, 80 and over; Caffeine; Cardiovascular Diseases; Depressive Disorder; Electroconvulsive T | 1990 |
Report of Fifth International Caffeine Workshop, Cancun, 1984.
Topics: Animals; Breast Diseases; Caffeine; Carcinogens; Cardiovascular Diseases; Congresses as Topic; Human | 1985 |
[Hypertension, obesity, alcohol, tobacco and caffeine consumption before vascular diseases, in the statutory community of Navarra].
Topics: Adult; Aged; Alcohol Drinking; Caffeine; Cardiovascular Diseases; Female; Humans; Hypertension; Male | 1987 |
Coffee, caffeine, and serum cholesterol in Japanese men in Hawaii.
Topics: Aged; Alcohol Drinking; Blood Pressure; Caffeine; Cardiovascular Diseases; Cholesterol; Coffee; Diet | 1986 |
Coffee drinking, smoking, pollution, and cardiovascular disease: a problem of self-selection.
Topics: Biogenic Amines; Blood-Brain Barrier; Brain; Caffeine; Cardiovascular Diseases; Chronic Disease; Cof | 1973 |
[Management of heart and circulation. 1. Circulatory agents].
Topics: Adrenergic alpha-Antagonists; Animals; Caffeine; Cardiovascular Diseases; Peptides; Theophylline; Va | 1973 |
[The treatment of heart and circulatory disorders. 1. Circulatory drugs].
Topics: Acridines; Angiotensin II; Animals; Blood Pressure; Caffeine; Cardiovascular Diseases; Cardiovascula | 1973 |
Influence of caffeine-containing beverage on the growth, food utilization and plasma lipids of the rat.
Topics: Animals; Caffeine; Cardiovascular Diseases; Cholesterol; Depression, Chemical; Diet; Diet, Atherogen | 1969 |